(Q54148024)

25 May 2018

title

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. (English)

1 reference

25 May 2018

main subject

anti-retroviral agent

0 references

1 reference

A Carr

1

1 reference

25 May 2018

D Marriott

2

1 reference

25 May 2018

A Field

3

1 reference

25 May 2018

E Vasak

4

1 reference

25 May 2018

D A Cooper

5

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

25 May 2018

published in

The Lancet

1 reference

25 May 2018

volume

351

1 reference

25 May 2018

issue

9098

1 reference

25 May 2018

page(s)

256-261

1 reference

25 May 2018

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Macrophages as a source of HIV during opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

The infectivity of Cryptosporidium parvum in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Cryptosporidium infection and CD4 counts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Small intestinal injury and parasitic diseases in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Oral administration of bovine colostrum anti-cryptosporidia antibody fails to alter the course of human cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

A phase I study of letrazuril in AIDS-related cryptosporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Effect of interferon-gamma in experimental Cryptosporidium parvum infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Differential requirements for survival and proliferation of CD8 naïve or memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

Cytokine gene expression in HIV-infected intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2907529-6

7 January 2021

10.1016/S0140-6736(97)07529-6

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018